Predicting flexural strength of hybrid FRP-steel reinforced beams using symbolic regression and ML techniques.

Publication date: Jun 25, 2025

Hybrid fiber-reinforced polymer (FRP) and steel reinforced concrete (hybrid FRP-steel RC) beams have gained recognition for their exceptional flexural performance, surpassing that of beams reinforced exclusively with FRP bars (FRP-RC). However, current design guidelines, such as ACI 440. 11-22, fail to accurately predict the flexural strength of these hybrid systems. This study aims to enhance the predictive accuracy and interpretability of flexural strength models by applying advanced computational approaches-specifically, machine learning (ML) techniques and symbolic regression. A robust dataset of 134 experimental data points was utilized to develop predictive models. The prediction results showed that both ML and symbolic regression models significantly outperformed the ACI 440. 11-22 equations, achieving lower errors (MAE, MAPE, RMSE) and higher accuracy (R). The results demonstrate that the ML models-Gaussian process regression (GPR), NGBoost, and CatBoost-achieved high predictive accuracy, with mean R values approaching 1. 0 and MAPE% as low as 5. 19 (training) and 11. 51 (testing) for GPR. Furthermore, symbolic regression yielded a transparent mathematical expression with a mean prediction ratio (u) of 1. 003, a CoV of 0. 139, and a MAPE% of 11. 08. These findings highlight the practical and technical advantages of symbolic regression in developing reliable, interpretable, and efficient design equations for hybrid FRP-steel RC beams.

Open Access PDF

Concepts Keywords
Catboost CatBoost model
Efficient Fiber-reinforced polymer
Flexural Flexural strength
Mathematical Machine learning
Outperformed Symbolic regression

Semantics

Type Source Name
disease IDO process
drug DRUGBANK Coenzyme M
drug DRUGBANK Spinosad
drug DRUGBANK Tricyclazole
drug DRUGBANK Flunarizine
disease IDO algorithm
disease MESH uncertainty
drug DRUGBANK Medroxyprogesterone acetate
drug DRUGBANK Isoxaflutole
disease MESH mutation rate
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Nonoxynol-9
pathway REACTOME Reproduction

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *